PhotonPharma, Inc. — Form D/A
PhotonPharma, Inc. of FORT COLLINS, CO, a company, filed a Form D amendment with the SEC on 2023-08-29. The offering totals $3.9M, of which $2.9M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2023-08-29
- Form: D/A
- Accession: 0001914950-23-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $3.9M
- Amount sold: $2.9M
- Remaining: $1.0M
- Investors: 8
- Date of first sale: 2022-01-31
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-437553
Issuer
- Name: PhotonPharma, Inc.
- CIK: 0001914950
- Entity type: Corporation
- Jurisdiction: COLORADO
- Incorporated: 2018
- Address: 3185 RAMPART ROAD, FORT COLLINS, CO, 80521
- Phone: 3038871014
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Milton Chang | Director | Boullder, CO |
| Terry Opgenorth | Director | Denver, CO |
| Terry Opgenorth | Executive Officer | Denver, CO |
| Wolfgang Baiker | Director | Fort Collins, CO |
| Gary Gordon | Director | Fort Collins, CO |
| Raymond Goodrich | Director | Fort Collins, CO |
| Alan Rudolph | Director | Fort Collins, CO |
| Alan Rudolph | Executive Officer | Fort Collins, CO |
Other filings by this issuer (2)
More